TABLE OF CONTENTS
Detailed Table of Contents
Chapter 1 — Executive Summary
1.1Market Overview
1.22025 Market Size and 2035 Forecast
1.3Largest and Fastest-Growing Segments
1.4Key Country and Regional Highlights
1.5Competitive Positioning
1.6Strategic Recommendations
Chapter 2 — Research Scope and Methodology
2.1Market Definitions and Boundaries
2.2Base Year and Forecast Period
2.3Primary Research
2.4Secondary Research
2.5Bottom-Up Market Estimation
2.6Top-Down Market Estimation
2.7Data Triangulation
2.8Forecast Assumptions and Limitations
Chapter 3 — Market Dynamics
3.1Growth Drivers
3.2Market Restraints
3.3Growth Opportunities
3.4Industry Challenges
3.5Emerging Trends
3.6Porter’s Five Forces
3.7Value Chain and Pricing Analysis
Chapter 4 — Technology, Regulatory and Commercial Landscape
4.1Technology Evolution
4.2Product Innovation and Pipeline
4.3Regulatory Approvals and Compliance
4.4Clinical and Performance Evidence
4.5Reimbursement and Payer Access
4.6Distribution and Procurement
4.7Digital Integration and Interoperability
Chapter 5 — Market Size and Forecast, 2025–2035
5.1Market Revenue, 2025–2035
5.2Year-on-Year Growth and CAGR
5.3Revenue by Segment
5.4Largest Segment and Growth Rationale
5.5Fastest-Growing Segment and Growth Rationale
5.6Forecast Scenarios and Sensitivities
Chapter 6 — Market Analysis, by Component
6.1Overview and Market Definition
6.2Revenue and Forecast, 2025–2035
6.3Subsegment Analysis
6.3.1Sensors: Disposable and Implantable
6.3.2Transmitters
6.3.3Receivers and Readers
6.3.4Software and Accessories
6.4Largest Subsegment: Share and Drivers
6.5Fastest-Growing Subsegment: CAGR and Drivers
6.6Competitive and Commercial Implications
Chapter 7 — Market Analysis, by Technology
7.1Overview and Market Definition
7.2Revenue and Forecast, 2025–2035
7.3Subsegment Analysis
7.3.1Real-Time CGM
7.3.2Intermittently Scanned CGM
7.3.3Implantable CGM
7.4Largest Subsegment: Share and Drivers
7.5Fastest-Growing Subsegment: CAGR and Drivers
7.6Competitive and Commercial Implications
Chapter 8 — Market Analysis, by Patient Type
8.1Overview and Market Definition
8.2Revenue and Forecast, 2025–2035
8.3Subsegment Analysis
8.3.1Type 1 Diabetes
8.3.2Type 2 Diabetes: Insulin-Treated
8.3.3Type 2 Diabetes: Non-Insulin-Treated
8.3.4Other Patient Groups
8.4Largest Subsegment: Share and Drivers
8.5Fastest-Growing Subsegment: CAGR and Drivers
8.6Competitive and Commercial Implications
Chapter 9 — Market Analysis, by End User
9.1Overview and Market Definition
9.2Revenue and Forecast, 2025–2035
9.3Subsegment Analysis
9.3.1Homecare
9.3.2Hospitals and Clinics
9.3.3Diabetes Centers
9.4Largest Subsegment: Share and Drivers
9.5Fastest-Growing Subsegment: CAGR and Drivers
9.6Competitive and Commercial Implications
Chapter 10 — Market Analysis, by Distribution Channel
10.1Overview and Market Definition
10.2Revenue and Forecast, 2025–2035
10.3Subsegment Analysis
10.3.1Hospital Pharmacies
10.3.2Retail Pharmacies
10.3.3Online and Direct-to-Consumer
10.4Largest Subsegment: Share and Drivers
10.5Fastest-Growing Subsegment: CAGR and Drivers
10.6Competitive and Commercial Implications
Chapter 11 — Country Analysis
11.1National Market Overview
11.2National Revenue and Forecast, 2025–2035
11.3Subnational Market and Access Analysis
11.3.1Northwest Italy
11.3.2Northeast Italy
11.3.3Central Italy
11.3.4Southern Italy
11.3.5Islands
11.4Regulatory and Reimbursement Framework
11.5Urban–Rural Access and Adoption Differences
11.6Healthcare Infrastructure and Distribution
11.7National Competitive Dynamics
Chapter 12 — Competitive Landscape
12.1Competitive Structure
12.2Market Share and Concentration
12.3Product and Technology Benchmarking
12.4Pricing and Distribution Benchmarking
12.5Mergers and Acquisitions
12.6Partnerships and Collaborations
12.7New Product Launches
12.8Geographic Expansion
Chapter 13 — Company Profiles
13.1Abbott
13.1.1Company Overview
13.1.2Relevant Product and Service Portfolio
13.1.3Financial Performance (Where Disclosed)
13.1.4Geographic Presence
13.1.5Recent Strategic Developments
13.1.6SWOT and Competitive Positioning
13.2Dexcom
13.2.1Company Overview
13.2.2Relevant Product and Service Portfolio
13.2.3Financial Performance (Where Disclosed)
13.2.4Geographic Presence
13.2.5Recent Strategic Developments
13.2.6SWOT and Competitive Positioning
13.3Medtronic
13.3.1Company Overview
13.3.2Relevant Product and Service Portfolio
13.3.3Financial Performance (Where Disclosed)
13.3.4Geographic Presence
13.3.5Recent Strategic Developments
13.3.6SWOT and Competitive Positioning
13.4Senseonics
13.4.1Company Overview
13.4.2Relevant Product and Service Portfolio
13.4.3Financial Performance (Where Disclosed)
13.4.4Geographic Presence
13.4.5Recent Strategic Developments
13.4.6SWOT and Competitive Positioning
13.5Ascensia Diabetes Care
13.5.1Company Overview
13.5.2Relevant Product and Service Portfolio
13.5.3Financial Performance (Where Disclosed)
13.5.4Geographic Presence
13.5.5Recent Strategic Developments
13.5.6SWOT and Competitive Positioning
13.6Roche Diabetes Care
13.6.1Company Overview
13.6.2Relevant Product and Service Portfolio
13.6.3Financial Performance (Where Disclosed)
13.6.4Geographic Presence
13.6.5Recent Strategic Developments
13.6.6SWOT and Competitive Positioning
13.7i-SENS
13.7.1Company Overview
13.7.2Relevant Product and Service Portfolio
13.7.3Financial Performance (Where Disclosed)
13.7.4Geographic Presence
13.7.5Recent Strategic Developments
13.7.6SWOT and Competitive Positioning
13.8Medtrum
13.8.1Company Overview
13.8.2Relevant Product and Service Portfolio
13.8.3Financial Performance (Where Disclosed)
13.8.4Geographic Presence
13.8.5Recent Strategic Developments
13.8.6SWOT and Competitive Positioning
13.9Sinocare
13.9.1Company Overview
13.9.2Relevant Product and Service Portfolio
13.9.3Financial Performance (Where Disclosed)
13.9.4Geographic Presence
13.9.5Recent Strategic Developments
13.9.6SWOT and Competitive Positioning
13.10MicroTech Medical
13.10.1Company Overview
13.10.2Relevant Product and Service Portfolio
13.10.3Financial Performance (Where Disclosed)
13.10.4Geographic Presence
13.10.5Recent Strategic Developments
13.10.6SWOT and Competitive Positioning
Chapter 14 — Appendix
14.1Market Definitions and Acronyms
14.2Currency and Exchange Rate Assumptions
14.3Forecast Modeling Notes
14.4Source and Data Limitations
14.5Research Disclaimer